BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3766343)

  • 1. [Prostatic cancer: pathological analysis of autopsied cases].
    Takahashi Y; Mayuzumi T; Satoh J
    Hinyokika Kiyo; 1986 Jun; 32(6):835-9. PubMed ID: 3766343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of pulmonary metastases in stage D2 prostate cancer patients.
    Nakamachi H; Suzuki H; Akakura K; Imamoto T; Ueda T; Ishihara M; Furuya Y; Ichikawa T; Igarashi T; Ito H
    Prostate Cancer Prostatic Dis; 2002; 5(2):159-63. PubMed ID: 12497007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-pathological study on prostatic cancer, stage A using step section technic].
    Yushita Y; Minami Y; Sakuragi T; Kusaba Y; Kanetake H; Shindo K; Saito Y; Hara T; Tasaki T
    Hinyokika Kiyo; 1987 Aug; 33(8):1185-92. PubMed ID: 3425518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and evaluation of the extent of cancer of the prostate].
    Heintz J; Le Fur R; Graïc Y; Hernandez J; Hun Seng S; Bézier J
    Sem Hop; 1983 Oct; 59(36):2557-60. PubMed ID: 6316515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The aggressiveness of prostatic cancer in relation to classification and grading].
    Mehlhorn J
    Z Urol Nephrol; 1988 Apr; 81(4):203-11. PubMed ID: 3400348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone metastasis of gastric cancer].
    Sudo H; Takagi Y; Katayanagi S; Hoshino S; Suda T; Hibi Y; Ito K; Tsutida A; Aoki T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1058-60. PubMed ID: 16912521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic prostatic adenocarcinoma.
    Arora VK; Bedi RS
    Indian J Chest Dis Allied Sci; 1986; 28(2):95-8. PubMed ID: 3596663
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous metastasis following laparoscopic pelvic lymphadenectomy for prostatic carcinoma.
    Bangma CH; Kirkels WJ; Chadha S; Schröder FH
    J Urol; 1995 May; 153(5):1635-6. PubMed ID: 7714993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis and treatment of carcinoma of the prostate with bone metastasis].
    Kawai T; Washizuka M; Yamauchi T; Ishibashi Y; Sumi S; Kokuho M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1704-9. PubMed ID: 3592710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features of stage D prostatic carcinoma].
    Kobayashi N; Yoshida K; Saitoh H; Tari K; Negishi T; Ohwada F; Saitoh T
    Hinyokika Kiyo; 1989 Sep; 35(9):1529-35. PubMed ID: 2816619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphatic metastasis in prostatic carcinoma. Diagnostic value of staging and transcutaneous needle biopsy].
    Rothenberger K; Hofstetter A; Pfeifer KJ; Voeth C; Pensel J
    Fortschr Med; 1980 Sep; 98(34):1279-82. PubMed ID: 7461533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate: prognostic influences of stage, tumor volume, grade, and margins of resection.
    Epstein JI
    Semin Oncol; 1994 Oct; 21(5):527-41. PubMed ID: 7939746
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate carcinoma metastatic to the cervical lymph nodes: report of two cases and review of the literature.
    Copeland B; Clark JM; Sura A; Kilpatrick SE; Shockley W; Meredith S
    Am J Otolaryngol; 2001; 22(6):420-3. PubMed ID: 11713729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy?
    Gingrich JR; Paulson DF
    Surg Oncol Clin N Am; 1995 Apr; 4(2):335-44. PubMed ID: 7540939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer of the prostate with predominant lymphatic manifestation. Apropos of 2 cases].
    Herer B; Waligora J; Delfraissy JF; Dormont J
    J Urol (Paris); 1987; 93(8):475-7. PubMed ID: 3440840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial metastatic adenocarcinoma of the prostate presenting as visual disturbance.
    Preston DM; Zeidman SM; Spevak M; Moul JW; Costabile RA
    Tech Urol; 1997; 3(1):51-3. PubMed ID: 9170227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.